Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation
published in: Clinical Lymphoma, Myeloma & Leukemia
date of publication: 2015-01-03
language: English
main subject: rituximab
Cites articles
There is nothing here
Article - wd:Q38346040